Moderna Officially Confirms Discussions to Supply 40 Million Vaccine Doses to Korea

Supply Starting from Q2 Following the Korean Government's Request for Rapid Delivery

[Asia Economy Reporter Naju-seok] The U.S. pharmaceutical company Moderna officially confirmed on the 29th that it has been in discussions with the Korean government to supply more than 40 million doses of the novel coronavirus (COVID-19) vaccine.

In a press release on the same day, Moderna stated, "We officially confirm that discussions are underway with the Korean government to supply 40 million doses or more of the COVID-19 vaccine as quickly as possible," adding, "According to the terms being discussed, supply could begin from the second quarter of next year."

Earlier, the Blue House introduced that President Moon Jae-in had agreed to receive an additional 20 million doses of the COVID-19 vaccine through Moderna CEO St?phane Bancel.

The Moderna vaccine requires two doses. Therefore, the announcement to supply 40 million doses corresponds to the Korean government's explanation.

A key Blue House official regarding the Moderna vaccine procurement contract said, "Although it initially seemed difficult to finalize the contract within this year, the timing of the contract was moved up following a call between President Moon and Moderna's CEO," adding, "We will proceed with negotiations aiming to conclude the contract within a few days."

This content was produced with the assistance of AI translation services.